Clinical trial · Interventional
Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the value of a nursing symptom support en selfmanagement intervention for adult patients with cancer treated with chemotherapy. Using a prospective sequential design with a comparison group who receives standard care and a (later) intervention group who gets the nursing intervention, we will evaluate the effect of this nursing intervention on overall symptom distress (primary outcome) and other measures of symptom burden, self-efficacy, outcome expectations and self-care. By conducting sem-structured interviews with some participants of the intervention group, we will study the patient experience of the intervention.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Chemotherapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nurse support and selfmanagement intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Comparison group
- description
- The comparison group will receive standard care.
- type
- ACTIVE_COMPARATOR
- label
- Intervention group
- description
- After completion of the comparison group, new patients starting chemotherapy treatment will be offered this study. Study participants will receive the nurse support and selfmanagement intervention.
- interventionNames
- Behavioral: Nurse support and selfmanagement intervention
Primary outcomes (2)
- measure
- Overall symptom distress
- timeFrame
- Longitudinal, during first 3 months after start of treatment
- description
- Summed symptom distress as self-reported on the Symptom Burden Questionnaire
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients starting first line treatment with (intravenous) chemotherapy * Ambulatory patients or patients who receive their treatment during short hospital stays * Regardless of type of cancer, treatment or treatment intention (curative or palliative) * Who understand sufficiently Dutch to fill out questionnaires * Who sign informed consent for their participation in the study Exclusion Criteria: * Oral anticancer treatment * Concomitant chemoradiotherapy * Breast cancer patients who receive nurse counseling throughout their therapy * Experimental therapy in the context of a clinical trial
References
Publications (0)
Data not yet available